Role of androgens in epilepsy

References

• Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin. Proc.71(6), 576–586 (1996).
   PubMed Web of Science ®Google Scholar
• Begley CE, Famular M, Annegers JF et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia.41, 342–351 (2000).
   PubMed Web of Science ®Google Scholar
• Kadir ZA, Chadwick DW. Principles of treatment of epilepsy. Drugs Today1, 35–41 (1999).
   Google Scholar
• Silverman A, Livne I, Witkin JW. The gonadatropin-releasing hormone (GnRH) neuronal systems: immunocytochemistry and in situ hybridization. In: The Physiology of Reproduction. Knobil E, Neill JD (Eds), 1683–1709 (1994).
   Google Scholar
• Everett JW. Pituitary and hypothalamus: perspectives and overview. In: The Physiology of Reproduction. Knobil E, Neill JD, (Eds), Raven Press, NY, USA 1509–1526 (1994).
   Google Scholar
• Baulieu EE, Robel P, Schumacher M. Neurosteroids: beginning of the story. Int. Rev. Neurobiol.46, 1–32 (2001).
   PubMed Web of Science ®Google Scholar
• Bloch M, Rubinow DR, Berlin K, Kevala KR, Kim HY, Schmidt PJ. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men. Arch. Gen. Psychiatry63, 450–456 (2006).
   PubMed Web of Science ®Google Scholar
• Mensah-Nyagan G, Do-Rego JL, Beaujean D, Luu-The V, Pelletier G, Vaudry H. Regulation of neurosteroid biosynthesis in the frog diencephalon by GABA and benzodiazepines. Horm. Behav.40, 218–225 (2001).
   PubMed Web of Science ®Google Scholar
• Brambilla F, Biggio G, Pisu MG et al. Plasma concentrations of anxiolytic neurosteroids in men with normal anxiety scores: a correlation analysis. Neuropsychobiology50, 6–9 (2004).
   PubMed Web of Science ®Google Scholar
• Paul SM, Purdy RH. Neuroactive steroids. FASEB J.6, 2311–2322 (1992).
   PubMed Web of Science ®Google Scholar
• Patchev VK, Almeida OF. Gonadal steroids exert facilitating and “buffering” effects on glucocorticoid-mediated transcriptional regulation of corticotropin-releasing hormone and corticosteroid receptor genes in rat brain. J. Neurosci.16, 7077–7084 (1996).
   PubMed Web of Science ®Google Scholar
• Barbaccia ML, Serra M, Purdy RH, Biggio G. Stress and neuroactive steroids. Int. Rev. Neurobiol.46, 243–272 (2001).
   PubMed Web of Science ®Google Scholar
• Frye CA, Rhodes ME, Petralia SM, Walf AA, Sumida K, Edinger KL. 3e-hydroxy-5e-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors. Neuroscience38, 1007–1014 (2006).
   Google Scholar
• Schumacher M, Weill-Engerer S, Liere P et al. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol.71, 3–29 (2003).
   PubMed Web of Science ®Google Scholar
• Grosso S, Luisi S, Mostardini R et al. Inter-ictal and post-ictal circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in epileptic children. Epilepsy Res.54, 29–34 (2003).
   PubMed Web of Science ®Google Scholar
• Gray GD. Changes in the levels of luteinizing hormone and testosterone in the circulation of ageing male rats. J. Endocrinol.76, 551–552 (1978).
   PubMed Web of Science ®Google Scholar
• Chambers KC, Phoenix CH. Testosterone and the decline of sexual behavior in aging male rats. Behav. Neural. Biol.40, 87–97 (1984).
   PubMedGoogle Scholar
• Foldvary-Schaefer N, Falcone T. Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology61, S2–S15 (2003).
   Web of Science ®Google Scholar
• Nemeroff CB. NeuroEndocrinology. CRC Press, Ann Arbor, MI, USA 1–512 (1992)
   Google Scholar
• Harden CL, Baker GA, Frye CA, Montouris GD, Pennell PB, Zupanc ML. Epilepsy and ovarian hormones. Neurology (Suppl.) 1–16 (2005).
   Google Scholar
• Beyenburg S, Stoffel-Wagner B et al. Neuroactive steroids and seizure susceptibility. Epilepsy Res.44, 141–153 (2001).
   PubMed Web of Science ®Google Scholar
• Terasawa E, Timiras PS. Electrical activity during the estrous cycle of the rat: cyclic changes in limbic structures. Endocrinology83, 207–216 (1968).
   PubMed Web of Science ®Google Scholar
• Frye CA, Rhodes ME. Estrogen-priming can enhance progesterone’s antiseizure effects in part by increasing hippocampal levels of allopregnanolone. Pharmacol. Biochem. Behav.81, 907–916 (2005).
   PubMed Web of Science ®Google Scholar
• Schwartz-Giblin S, Korotzer A, Pfaff DW. Steroid hormone effects on picrotoxin-induced seizures in female and male rats. Brain Res.476, 240–247 (1989).
   PubMed Web of Science ®Google Scholar
• Veliskova J, Velisek L, Galanopoulou AS, Sperber EF. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia.41(Suppl. 6), S30–S35 (2000).
   PubMed Web of Science ®Google Scholar
• Bäckstrom T, Zetterlund B, Blom S, Romano M. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol. Scand.69, 240–248 (1984).
   PubMed Web of Science ®Google Scholar
• Rhodes ME, Harney JP, Frye CA. Gonadal, adrenal, and neuroactive steroids’ role in ictal activity. Brain Res.1000, 8–18 (2004).
   PubMed Web of Science ®Google Scholar
• Scharfman HE. Absence of information about hormones and absence. Epilepsy Curr.5, 101–103 (2005).
   PubMedGoogle Scholar
• Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia.38, 1082–1088 (1997).
   PubMed Web of Science ®Google Scholar
• Harden CL, Pulver MC, Ravdin L, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia.40, 1402–1407 (1999).
   PubMed Web of Science ®Google Scholar
• Edwards HE, Burnham WM, Mendonca A, Bowlby DA, MacLusky NJ. Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats. Brain Res.38, 136–150 (1999).
   Google Scholar
• Kalkbrenner KA, Standley CA. Estrogen modulation of NMDA-induced seizures in ovariectomized and non-ovariectomized rats. Brain Res.964, 244–249 (2003).
   PubMed Web of Science ®Google Scholar
• Scharfman HE, Goodman JH, Rigoulot MA et al. Seizure susceptibility in intact and ovariectomized female rats treated with the convulsant pilocarpine. Exp. Neurol.196, 73–86 (2005).
   PubMed Web of Science ®Google Scholar
• Scharfman HE, Maclusky NJ. Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue? Trends Neurosci.28, 79–85 (2005).
   PubMed Web of Science ®Google Scholar
• Cheng YJ, Karavolas HJ. Conversion of progesterone to 5e-pregnane3,20-dione and 3e-hydroxy-5e-pregnan-20-one by rat medical basal hypothalami and the effects of estradiol and stage of estrous cycle on the conversion. Endocrinology93, 1157–1162 (1973).
   PubMed Web of Science ®Google Scholar
• Vongher JM, Frye CA. Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration. Pharmacol. Biochem. Behav.64, 777–785 (1999).
   PubMed Web of Science ®Google Scholar
• Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology45, 1660–1662 (1995).
   PubMed Web of Science ®Google Scholar
• Frye CA, Bayon LE. Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3e,5e-THP. Neuroendocrinol.68, 272–280 (1998).
   PubMed Web of Science ®Google Scholar
• Frye CA, Bayon LE. Cyclic withdrawal from endogenous and exogenous progesterone increases kainic acid and perforant pathway induced seizures. Pharmacol. Biochem. Behav.62, 315–321 (1999).
   PubMed Web of Science ®Google Scholar
• Frye CA, Scalise TJ. Antiseizure effects of progesterone and 3α,5α-THP in kainic acid and perforant pathway models of epilepsy. Psycho. Neuroendocrinol.4, 407–420 (2000).
   Google Scholar
• Hoffman GE, Moore N, Fiskum G, Murphy AZ. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp. Neurol.182, 124–134 (2003).
   PubMed Web of Science ®Google Scholar
• Ruusa J, Bergman B. Sex hormones and alcohol withdrawal: does a good supply of testosterone prevent serious symptoms during detoxification? Alcohol13, 139–145 (1996).
   PubMed Web of Science ®Google Scholar
• Badalian LO, Temin PA, Mukhin K. Effect of testenate in the treatment of epilepsy in men. ZH Nevropatol. Psikhiatr. Im. SS Korsakova91, 44–47 (1991).
   PubMedGoogle Scholar
• Herzog AG, Klein P, Jacobs AR. Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Neurology50, 782–784 (1998).
   PubMed Web of Science ®Google Scholar
• Harden C, MacLusky NJ. Aromatase inhibition, testosterone and seizures. Epilepsy Behav.5, 260–263 (2004).
   PubMed Web of Science ®Google Scholar
• Farwell JR, Blackner G, Sulzbacher S, Adelman L, Voeller M. First febrile seizures. Characteristics of the child, the seizure, and the illness. Clin. Pediatr.33, 263–267 (1994).
   PubMed Web of Science ®Google Scholar
• Kokka N, Sapp DW, Witte U, Olsen RW. Sex differences in sensitivity to pentylenetetrazol but not in GABAA receptor binding. Pharmacol. Biochem. Behav.43, 441–447 (1992).
   PubMed Web of Science ®Google Scholar
• Pericic D, Manev H, Bujas M. Gonadal hormones and picrotoxin-induced convulsions in male and female rats. Brain Res.736, 174–179 (1996).
   PubMed Web of Science ®Google Scholar
• Rhodes ME, McCormick CM, Frye CA. 3α,5α-THP mediates progestins’ effects to protect against adrenalectomy-induced cell death in the dentate gyrus of female and male rats. Pharmacol. Biochem. Behav.78, 505–512 (2004).
   PubMed Web of Science ®Google Scholar
• Chakraborty TR, Gore AC. Aging-related changes in ovarian hormones, their receptors, and neuroendocrine function. Exp. Biol. Med.229, 977–987 (2004).
   Web of Science ®Google Scholar
• Edwards HE, Burnham WM, MacLusky NJ. Testosterone and its metabolites affect afterdischarge thresholds and the development of amygdala kindled seizures. Brain Res.838(1–2), 151–157 (1999).
   PubMed Web of Science ®Google Scholar
• Pesce ME, Acevedo X, Pinardi G, Miranda HF. Gender differences in diazepam withdrawal syndrome in mice. Pharmacol. Toxicol.75, 353–355 (1994).
   PubMedGoogle Scholar
• Frye CA, Reed TA. Androgenic neurosteroids: antiseizure effects in an animal model of epilepsy. Psycho. Neuroendocrinol.23, 385–399 (1998).
   PubMed Web of Science ®Google Scholar
• Kaminski RM, Marini H, Kim WJ, Rogawski MA. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia46, 819–827 (2005).
   PubMed Web of Science ®Google Scholar
• Reddy DS. Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3e-androstanediol and 17f-estradiol. Neuroscience129, 195–207 (2004).
   PubMed Web of Science ®Google Scholar
• Iswari S, Colas AE, Karavolas HJ. Binding of 5e-dihydroprogesterone and other progestins to female rat anterior pituitary nuclear extracts. Steroids47, 189–203 (1986).
   PubMed Web of Science ®Google Scholar
• Smith HE, Smith RG, Toft DO, Neergaard JR, Burrows EP, O’Malley BW. Binding of steroids to progesterone receptor proteins in chick oviduct and human uterus. J. Biol. Chem.249, 5924–5932 (1974).
   PubMed Web of Science ®Google Scholar
• Roselli CE, Handa RJ, Resko JA. Quantitative distribution of nuclear androgen receptors in microdissected areas of the rat brain. Neuroendocrinology49, 449–453 (1989).
   PubMed Web of Science ®Google Scholar
• Harding SM, McGinnis MY. Androgen receptor blockade in the MPOA or VMN: effects on male sociosexual behaviors. Physiol. Behav.81, 671–680 (2004).
   PubMed Web of Science ®Google Scholar
• Brown TJ, Adler GH, Sharma M, Hochberg RB, MacLusky NJ. Androgen treatment decreases estrogen receptor binding in the ventromedial nucleus of the rat brain: a quantitative in vitro autoradiographic analysis. Mol. Cell Neurosci.5, 549–555 (1994).
   PubMed Web of Science ®Google Scholar
• Lieberburg I, MacLusky N, McEwen BS. Cytoplasmic and nuclear estradiol-17β binding in male and female rat brain: regional distribution, temporal aspects and metabolism. Brain Res.193, 487–503 (1980).
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Lemmen JG, Carlsson B et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology139, 4252–4263 (1998).
   PubMed Web of Science ®Google Scholar
• Pak TR, Chung WC, Lund TD, Hinds LR, Clay CM, Handa RJ. The androgen metabolite, 5e-androstane-3f.17f-diol (3f-Adiol), is a potent modulator of estrogen receptor-β1-mediated gene transcription in neuronal cells. Endocrinology146, 147–155 (2005).
   PubMed Web of Science ®Google Scholar
• Weihua Z, Lathe R, Warner M, Gustafsson JA. An endocrine pathway in the prostate, ERf, AR, 5e-androstane-3f, 17f-diol, and CYP7B1, regulates prostate growth. Proc. Natl Acad. Sci. USA99, 13589–13594 (2002).
   PubMed Web of Science ®Google Scholar
• Kuiper TB, Langer WD, Velusamy T. Evolutionary status of the pre-protostellar core L1498. Astrophys. J.468, 761–773 (1996).
   PubMed Web of Science ®Google Scholar
• Tremblay GB, Tremblay A, Copeland NG et al. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol. Endocrinol.11, 353–365 (1997).
   PubMed Web of Science ®Google Scholar
• Green S, Walter P, Kumar V et al. Human oestrogen receptor cDNA: sequence, expression and homology to ERf-e. Nature320, 134–139 (1986).
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Carlsson B, Grandien K et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology138, 863–870 (1997).
   PubMed Web of Science ®Google Scholar
• Paech K, Webb P, Kuiper GG et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science2771, 508–510 (1997).
   Google Scholar
• Tena-Sempere M, Navarro VM, Mayen A, Bellido C, Sanchez-Criado JE. Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in the female rat pituitary. Biol. Reprod.70, 671–678 (2004).
   PubMed Web of Science ®Google Scholar
• Shughrue P, Scrimo P, Lane M, Askew R, Merchenthaler I. The distribution of estrogen receptor-β mRNA in forebrain regions of the estrogen receptor-α knockout mouse. Endocrinology138, 5649–5652 (1997).
   PubMed Web of Science ®Google Scholar
• Melcangi RC, Magnaghi V, Galbiati M, Martini L. Formation and effects of neuroactive steroids in the central and peripheral nervous system. Int. Rev. Neurobiol.46, 145–176 (2001).
   PubMed Web of Science ®Google Scholar
• Engel SR, Grant KA. Neurosteroids and behavior. Int. Rev. Neurobiol.46, 321–348 (2001).
   PubMed Web of Science ®Google Scholar
• Frye CA, Manjarrez J, Camacho-Arroyo I. Infusion of 3α,5α-THP to the pontine reticular formation attenuates PTZ-induced seizures. Brain Res.881, 98–102 (2000).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Frye CA. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann. Neurol.53, 390–391 (2003).
   PubMed Web of Science ®Google Scholar
• Rhodes ME, Frye CA. Progestins in the hippocampus of female rats have antiseizure effects in a pentylenetetrazole seizure model. Epilepsia45, 1531–1538 (2004).
   PubMed Web of Science ®Google Scholar
• Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science232, 1004–1007 (1986).
   PubMed Web of Science ®Google Scholar
• Rosciszewska D, Buntner B, Guz I, Zawisza L. Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. J. Neurol. Neurosurg. Psychiatry49, 47–51 (1986).
   PubMed Web of Science ®Google Scholar
• Frye CA, Scalise TJ, Bayon LE. Finasteride blocks the reduction in ictal activity produced by exogenous estrous cyclicity. J. Neuroendocrinol.10, 291–296 (1998).
   PubMed Web of Science ®Google Scholar
• Kokate TG, Banks MK, Magee T, Yamaguchi S, Rogawski MA. Finasteride. A 5α-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J. Pharmacol. Exp. Ther.288, 679–684 (1999).
   PubMed Web of Science ®Google Scholar
• Frye CA, Rhodes ME, Walf A, Harney J. Progesterone reduces pentylenetetrazol-induced ictal activity of wild-type mice but not those deficient in type I 5α-reductase. Epilepsia5, 14–17 (2002).
   Google Scholar
• Gee KW. Steroid modulation of the GABA/benzodiazepine receptor-linked chloride ionophore. Mol. Neurobiol.2, 291–317 (1988).
   PubMed Web of Science ®Google Scholar
• Frye CA, Duncan JE, Basham M, Erskine MS. Behavioral effects of 3 α-androstanediol. II: Hypothalamic and preoptic area actions via a GABAergic mechanism. Behav. Brain Res.79, 119–130 (1996).
   PubMed Web of Science ®Google Scholar
• Frye CA, Van Keuren KR, Erskine MS. Behavioral effects of 3 α-androstanediol. I: Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav. Brain Res.79, 109–118 (1996).
   PubMed Web of Science ®Google Scholar
• Frye CA, Rhodes ME, Walf AA, Harney JP. Testosterone reduces pentylenetetrazole-induced ictal activity of wild-type mice but not those deficient in type I 5α-reductase. Brain Res.918, 182–186 (2001).
   PubMed Web of Science ®Google Scholar
• Edeh J, Toone B. Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice. Br. J. Psychiatry151, 95–101 (1987).
   PubMed Web of Science ®Google Scholar
• Gilliam F, Hecimovic H, Sheline Y. Psychiatric comorbidity, health, and function in epilepsy. Epilepsy Behav.4, 26–30 (2003).
   PubMed Web of Science ®Google Scholar
• Gureje O. Interictal psychopathology in epilepsy. Prevalence and pattern in a Nigerian clinic. Br. J. Psychiatry158, 700–705 (1991).
   PubMed Web of Science ®Google Scholar
• Hermann BP, Seidenberg M, Bell B. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia.41, 31–41 (2000).
   PubMed Web of Science ®Google Scholar
• Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia.37, 148–161 (1996).
   PubMed Web of Science ®Google Scholar
• Manchanda R, Schaefer B, McLachlan RS et al. Psychiatric disorders in candidates for surgery for epilepsy. J. Neurol. Neurosurg. Psychiatry61, 82–89 (1996).
   PubMed Web of Science ®Google Scholar
• Pariente PD, Lepine JP, Lellouch J. Lifetime history of panic attacks and epilepsy: an association from a general population survey. J. Clin. Psychiatry52, 88–89 (1991).
   PubMedGoogle Scholar
• Perini GI, Tosin C, Carraro C et al. Interictal mood and personality disorders in temporal lobe epilepsy and juvenile myoclonic epilepsy. J. Neurol. Neurosurg. Psychiatry61, 601–605 (1996).
   PubMed Web of Science ®Google Scholar
• Scicutella A, Ettinger BA. Treatment of anxiety in epilepsy. Epilepsy Behav.5, 10–12 (2002).
   Google Scholar
• Adamec RE. Amygdala kindling and anxiety in the rat. Neuroreport1, 255–258 (1990).
   PubMedGoogle Scholar
• Swanson SJ, Rao SM, Grafman J, Salazar AM, Kraft J. The relationship between seizure subtype and interictal personality. Results from the Vietnam Head Injury Study. Brain118, 91–103 (1995).
   PubMed Web of Science ®Google Scholar
• Erdogan F, Golgeli A, Arman F, Ersoy AO. The effects of pentylenetetrazole-induced status epilepticus on behavior, emotional memory, and learning in rats. Addict Behav.5, 388–393 (2004).
   Google Scholar
• File SE, Lister RG. Do the reductions in social interaction produced by picrotoxin and pentylenetetrazole indicate anxiogenic actions? Neuropharmacology23(7A), 793–796 (1984).
   PubMed Web of Science ®Google Scholar
• Szyndler J, Rok P, Maciejak P et al. Effects of pentylenetetrazol-induced kindling of seizures on rat emotional behavior and brain monoaminergic systems. Pharmacol. Biochem. Behav.73, 851–861 (2002).
   PubMed Web of Science ®Google Scholar
• File SE, Mabbutt PS, Becker A, Gonzalez LE, Fluck E. Short-term rebound anxiolytic effects and long-term changes in platelet benzodiazepine binding after pentylenetetrazole-kindling in two strains of rat. Anxiety2, 109–116 (1996).
   PubMedGoogle Scholar
• Devinsky O. Introduction: managing epilepsy in special populations. Rev. Neurol. Dis.1, 3 (2004).
   Google Scholar
• Abrahams S, Morris RG, Polkey CE et al. Hippocampal involvement in spatial and working memory: a structural MRI analysis of patients with unilateral mesial temporal lobe sclerosis. Brain Cogn.41, 39–65 (1999).
   PubMed Web of Science ®Google Scholar
• Helmstaedter C. Effects of chronic epilepsy on declarative memory systems. Prog. Brain Res.135, 439–453 (2002).
   PubMedGoogle Scholar
• Collier TJ, Routtenberg A. Selective impairment of declarative memory following stimulation of dentate gyrus granule cells: a naloxone-sensitive effect. Brain Res.310, 384–387 (1984).
   PubMed Web of Science ®Google Scholar
• Mathern GW, Adelson PD, Cahan LD, Leite JP. Hippocampal neuron damage in human epilepsy: Meyer’s hypothesis revisited. Prog. Brain Res.135, 237–251 (2002).
   PubMed Web of Science ®Google Scholar
• Mello LE, Cavalheiro EA, Tan AM et al. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia34, 985–995 (1993).
   PubMed Web of Science ®Google Scholar
• Schwarcz R, Zaczek R, Coyle JT. Microinjection of kainic acid into the rat hippocampus. Eur. J. Pharmacol.50, 209–220 (1978).
   PubMed Web of Science ®Google Scholar
• Franke H, Kittner H. Morphological alterations of neurons and astrocytes and changes in emotional behavior in pentylenetetrazol-kindled rats. Pharmacol. Biochem. Behav.70, 291–303 (2001).
   PubMed Web of Science ®Google Scholar
• Sloviter RS. “Epileptic” brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies. Brain Res. Bull.10, 675–697 (1983).
   PubMed Web of Science ®Google Scholar
• Kotloski R, Lynch M, Lauersdorf S, Sutula T. Repeated brief seizures induce progressive hippocampal neuron loss and memory deficits. Prog. Brain Res.135, 95–110 (2002).
   PubMed Web of Science ®Google Scholar
• Grecksch U, Becker A, Gadau C, Matthies H. Gangliosides improve a memory deficit in pentylentetrazol-kindled rats. Pharmacol. Biochem. Behav.39, 825–828 (1991).
   PubMed Web of Science ®Google Scholar
• Genkova-Papazova M, Lazarova-Bakarov M. Pentylenetetrazole kindling impairs long-term memory in rats. Eur. Neuropsychopharmacol.5, 53–56 (1995).
   PubMed Web of Science ®Google Scholar
• Genkova-Papazova B, Petkova N, Shishkova M, Lazarova-Bakarova MG. The GABA-B antagonist CGP 36742 prevent PTZ-kindling-provoked amnesia in rats. Eur. Neuropsychopharmacol.10, 273–278 (2000).
   PubMed Web of Science ®Google Scholar
• Morrell MJ. Epilepsy in women: the science of why it is special. Neurology53, S42–S48 (1999).
   Web of Science ®Google Scholar
• Morrell MJ. Hormones and epilepsy through the lifetime. Epilepsia33, S49–S61 (1992).
   Google Scholar
• Trimble MR. Serum prolactin in epilepsy and hysteria. Br. Med. J.2, 1682 (1978).
   PubMedGoogle Scholar
• Pritchard PB 3rd, Wannamaker BB, Sagel J, Nair R, DeVillier C. Endocrine function following complex partial seizures. Ann. Neurol.14, 27–32 (1983).
   PubMed Web of Science ®Google Scholar
• Dana-Haeri J, Trimble M, Oxley J. Prolactin and gonadotrophin changes following generalised and partial seizures. J. Neurol. Neurosurg. Psychiatry46, 331–335 (1983).
   PubMed Web of Science ®Google Scholar
• Bilo L, Meo R, Valentino R, Buscaino GA, Striano S, Nappi C. Abnormal pattern of luteinizing hormone pulsatility in women with epilepsy. Fertil. Steril.55, 705–711 (1991).
   PubMed Web of Science ®Google Scholar
• Drislane FW, Coleman AE, Schomer DL et al. Altered pulsatile secretion of luteinizing hormone in women with epilepsy. Neurology44, 306–310 (1994).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Drislane FW, Schomer DL, et al. Abnormal pulsatile secretion of luteinizing hormone in men with epilepsy: relationship to laterality and nature of paroxysmal discharges. Neurology40, 1557–1561 (1990).
   PubMed Web of Science ®Google Scholar
• Molaie M, Culebras A, Miller M. Effect of interictal epileptiform discharges on nocturnal plasma prolactin concentrations in epileptic patients with complex partial seizures. Epilepsia27, 724–728 (1986).
   PubMed Web of Science ®Google Scholar
• Cerullo A, Tinuper P, Provini F et al. Autonomic and hormonal ictal changes in gelastic seizures from hypothalamic hamartomas. Electroencephalogr. Clin. Neurophysiol.107, 317–322 (1998).
   PubMedGoogle Scholar
• Herzog AG, Coleman AE, Jacobs AR et al. Relationship of sexual dysfunction to epilepsy laterality and reproductive hormone levels in women. Epilepsy Behav.4, 407–413 (2003).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N. Reproductive endocrine disorders in men with partial seizures of temporal lobe origin. Arch. Neurol.43, 347–350 (1986).
   PubMed Web of Science ®Google Scholar
• Bauer J, Isojarvi JI, Herzog AG et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J. Neurol. Neurosurg. Psychiatry73, 121–125 (2002).
   PubMed Web of Science ®Google Scholar
• Bilo L, Meo R, Valentino R, Di Carlo C, Striano S, Nappi C. Characterization of reproductive endocrine disorders in women with epilepsy. J. Clin. Endocrinol. Metab.86, 2950–2956 (2001).
   PubMed Web of Science ®Google Scholar
• Herzog AG. Altered reproductive endocrine regulation in men with epilepsy: implications for reproductive function and seizures. Ann. Neurol.51, 539–542 (2002).
   PubMed Web of Science ®Google Scholar
• Crowley WF Jr, Filicori M, Spratt DI, Santoro NF. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog. Horm. Res.41, 473–531 (1985).
   PubMedGoogle Scholar
• Isojarvi JI, Lofgren E, Juntunen KS et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology62, 247–253 (2004).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Drislane FW, Schomer DL et al. Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology65, 1016–1020 (2005).
   PubMed Web of Science ®Google Scholar
• Edwards HE, MacLusky NJ, Burnham WM. The effect of seizures and kindling on reproductive hormones in the rat. Neurosci. Biobehav. Rev.24, 753–762 (2000).
   PubMed Web of Science ®Google Scholar
• Amado D, Cavalheiro EA, Bentivoglio M. Epilepsy and hormonal regulation: the patterns of GnRH and galanin immunoreactivity in the hypothalamus of epileptic female rats. Epilepsy Res.14, 149–159 (1993).
   PubMed Web of Science ®Google Scholar
• Friedman MN, Geula C, Holmes GL, Herzog AG. GnRH-immunoreactive fiber changes with unilateral amygdala-kindled seizures. Epilepsy Res.52, 73–77 (2002).
   PubMed Web of Science ®Google Scholar
• Edwards HE, Burnham WM, MacLusky NJ. Testosterone and its metabolites affect afterdischarge thresholds and the development of amygdala kindled seizures. Brain Res.838, 151–157 (1998).
   Web of Science ®Google Scholar
• Locock C. Analysis of fifty-two cases of epilepsy observed by the author. Lancet527–528 (1857).
   Google Scholar
• Cramer JA, Fisher R, Ben-Menachem E, French J, Mattson RH. New antiepileptic drugs: comparison of key clinical trials. Epilepsia40, 590–600 (1999).
   PubMed Web of Science ®Google Scholar
• Besag FMC. Behavioural effects of the newer antiepileptic drugs: an update. Exp. Opin. Drug Saf.3, 1–8 (2004).
   PubMedGoogle Scholar
• Boylan LS, Boylan O, Devinsky JJ, Barry TA. Psychiatric uses of antiepileptic treatments. Epilepsy Behav.3, 54 (2002).
   PubMedGoogle Scholar
• Rogawski MA, Loscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat. Med.10, 685 (2004).
   PubMed Web of Science ®Google Scholar
• Griffith NM, Szaflarski JP, Szaflarski M et al. Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS Depression scale as an alternative to the BDI-II. Epilepsy Behav.7, 266–272 (2005).
   PubMed Web of Science ®Google Scholar
• Schachter SC. Improving quality of life beyond seizure control. Epileptic Disord.7, 34–38 (2005).
   Google Scholar
• Calabrese JR, Calabrese CL, Bowden GS et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J. Clin. Psychiatry60, 79–88 (1999).
   PubMed Web of Science ®Google Scholar
• Gilliam FG, Santos J, Vahle V, Carter J, Brown K, Hecimovic H. Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction? Epilepsia.45, 28–33 (2004).
   PubMed Web of Science ®Google Scholar
• Kanner JJ, Barry AM. Is the psychopathology of epilepsy different from that of nonepileptic patients? Epilepsy Behav.2, 170–186 (2001).
   PubMed Web of Science ®Google Scholar
• Nagahata M. Neuropsychological and psychiatric problems in epileptic children. No To Hattatsu22, 143–148 (1990).
   PubMedGoogle Scholar
• Stores G. Behavioural effects of anti-epileptic drugs. Dev. Med. Child Neurol.17, 647–658 (1975).
   PubMed Web of Science ®Google Scholar
• Meador KJ, Loring DW, Allen M et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology41, 1537–1540 (1991).
   PubMed Web of Science ®Google Scholar
• Meador KJ, Loring DW, Abney OL et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia34, 153–157 (1993).
   PubMed Web of Science ®Google Scholar
• Meador KJ, Loring DW, Moore EE et al. Comparative cognitive effects of phenobarbital, phenytoin and valproate in healthy subjects. Neurology45, 1494–1499 (1995).
   PubMed Web of Science ®Google Scholar
• Meador KJ. Cognitive and memory effects of the new antiepileptic drugs. Epilepsy Res.68, 63–67 (2006).
   PubMed Web of Science ®Google Scholar
• Voigt JP, Morgenstern E. Comparative effects of carbamazepine, phenytoin, diazepam and clonazepam on inhibitory avoidance learning in mice. Psychopharmacology (Berl).108, 131–135 (1992).
   PubMed Web of Science ®Google Scholar
• Connell JM, Rapeport WG, Beastall GH, Brodie MJ. Changes in circulating androgens during short term carbamazepine therapy. Br. J. Clin. Pharmacol.17, 347–351 (1984).
   PubMed Web of Science ®Google Scholar
• Barragry JM, Makin HL, Trafford DJ, Scott DF. Effect of anticonvulsants on plasma testosterone and sex hormone binding globulin levels. J. Neurol. Neurosurg. Psychiatry41, 913–914 (1978).
   PubMed Web of Science ®Google Scholar
• Toone BK, Wheeler M, Nanjee M, Fenwick P, Grant R. Sex hormones, sexual activity and plasma anticonvulsant levels in male epileptics. J. Neurol. Neurosurg. Psychiatry46, 824–826 (1983).
   PubMed Web of Science ®Google Scholar
• Vecht CJ, Wagner GL, Wilms EB. Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol.2, 404–409 (2003).
   PubMed Web of Science ®Google Scholar
• Harden CL, Baker GA, Frye CA, Montouris GD, Pennell PB, Zupanc ML. Epilepsy and ovarian hormones. Neurology (Suppl.) 16–29 (2005).
   Google Scholar
• Pennell PB. Using current evidence in selecting antiepileptic drugs for use during pregnancy. Epilepsy Curr.5, 45–51 (2005).
   PubMedGoogle Scholar
• Isojärvi JI, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllyla VV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann. Neurol.39, 579–584 (1996).
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N. Engl. J. Med.329, 1383–1388 (1993).
   PubMed Web of Science ®Google Scholar
• Isojarvi JI, Pakarinen AJ, Ylipalosaari PJ, Myllyla VV. Serum hormones in male epileptic patients receiving anticonvulsant medication. Arch. Neurol.47, 670–676 (1990).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Drislane FW, Schomer DL, et al. Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy: interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs. Epilepsia45, 764–768 (2004).
   PubMed Web of Science ®Google Scholar
• Murialdo G, Galimberti CA, Fonzi S et al. Sex hormones and pituitary function in male epileptic patients with altered or normal sexuality. Epilepsia36, 360–365 (1995).
   PubMed Web of Science ®Google Scholar
• Derry PA. Psychological treatment in intractable epilepsy: approaches, evidence, and future directions. Adv. Neurol.97, 375–380 (2006).
   PubMedGoogle Scholar
• Trost LF 3rd, Wender RC, Suter CC et al. National Epilepsy Management Panel. Management of epilepsy in adults. Treatment guidelines. Postgrad. Med.118, 29–33 (2005).
   PubMed Web of Science ®Google Scholar
• Bäckström T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol. Scand.54, 321–347 (1976).
   PubMed Web of Science ®Google Scholar
• Shavit G, Lerman P, Korczyn AD, Kivity S, Bechar M, Gitter S. Phenytoin pharmacokinetics in catamenial epilepsy. Neurology34, 959–961 (1984).
   PubMed Web of Science ®Google Scholar
• Krishnamurthy KB, Schomer DL. Weekly fluctuation and adjustment of antiepileptic drugs to treat catamenial epilepsy. Epilepsia39, 179 (1998).
   Google Scholar
• Tatum WO IV, Liporace J, Benbadis SR, Kaplan PW. Updates on the treatment of epilepsy in women. Arch. Intern. Med.164, 137–145 (2004).
   PubMed Web of Science ®Google Scholar
• Spina E, Perucca E. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia43, 37–44 (2002).
   PubMed Web of Science ®Google Scholar
• Mellon SH, Griffin LD. Synthesis, regulation, and function of neurosteroids. Endocr. Res.28, 463 (2002).
   PubMed Web of Science ®Google Scholar
• Uzunova V, Sampson L, Uzunov DP. Relevance of endogenous 3α-reduced neurosteroids to depression and antidepressant action. Psychopharmacology (Berl.)1–11 (2006).
   Google Scholar